Combining GLP-1 and glucagon for the treatment of obesity and diabetes

被引：0
|
作者：
Idris, Iskandar [1 ]
机构：
[1] Univ Nottingham, Nottingham NG7 2RD, England
来源：
DIABETES OBESITY & METABOLISM | 2013年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：481 / 482
页数：2
相关论文
共 50 条
  • [41] Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
    Seghieri, Marta
    Christensen, Alexander S.
    Andersen, Andreas
    Solini, Anna
    Knop, Filip K.
    Vilsboll, Tina
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [42] Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
    Tasyurek, Hale M.
    Eksi, Yunus Emre
    Altunbas, Hasan Ali
    Balci, Mustafa Kemal
    Sanlioglu, Salih
    HUMAN GENE THERAPY, 2014, 25 (11) : A87 - A88
  • [43] Glucagon-like peptide-1 (GLP-1):: a gut hormone of potential interest in the treatment of diabetes
    Ahrén, B
    BIOESSAYS, 1998, 20 (08) : 642 - 651
  • [44] Efpeglenatide Glucagon-like peptide 1 (GLP-1) receptor agonist Treatment for type 2 diabetes
    Reid, J.
    Rana, K.
    Segel, S. A.
    Sheikh-Ali, M.
    Choksi, R. R.
    Goldfaden, R. F.
    DRUGS OF THE FUTURE, 2019, 44 (06) : 435 - 441
  • [45] ALBIGLUTIDE Glucagon-Like Peptide GLP-1 Receptor Agonist Treatment of Type 2 Diabetes
    Rosenstock, Julio
    Stewart, Murray W.
    DRUGS OF THE FUTURE, 2010, 35 (09) : 701 - 712
  • [46] Long-Acting GLP-1 and Glucagon Receptor Dual Agonists for the Treatment of Type 2 Diabetes
    You, Seohee
    Mcdonald, Mary
    Case, Martin
    Steiner, Derek
    Tat, Timothy
    Jenkinson, Celia
    Pick, Rebecca
    Hart, Juliet
    Moreno, Veronica
    Parise, Jason
    Yan, Wen
    Camacho, Raul
    Swanson, Ronald
    Chi, Ellen
    Demarest, Keith
    Leonard, James
    DIABETES, 2016, 65 : A274 - A274
  • [47] Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus
    Hare, Kristine Juul
    DANISH MEDICAL BULLETIN, 2010, 57 (09)
  • [48] Glucagon-like Peptides (GLP-1) Perspectives in Synucleinopathies Treatment
    Foltynie, Tom
    Athauda, Dilan
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (03): : 255 - 258
  • [49] The glucagon-like peptide-1 (GLP-1) drugs poised to conquer obesity
    Yin, Jun
    Liu, Yuexing
    Jia, Weiping
    CHINESE SCIENCE BULLETIN-CHINESE, 2024, 69 (35): : 5094 - 5099
  • [50] GLP-1 analogues in treatment of type 1 diabetes mellitus
    Toelle, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (42) : 2123 - 2126
12345